Idelalisib Active Not Recruiting Phase 3 Trials for Follicular Lymphoma (FL) / Small Lymphocytic Lymphoma (SLL) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02536300Dose Optimization Study of Idelalisib in Follicular Lymphoma